Article Details
Retrieved on: 2021-01-07 17:57:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
POINT Biopharma is licensing Avacta's pre|CISION FAP-sensitive activation platform for radiopharmaceuticals – radioisotopes bound to biological ...
Article found on: www.businessweekly.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here